vs
布鲁克菲尔德(BNT)与福泰制药(VRTX)财务数据对比。点击上方公司名可切换其他公司
福泰制药的季度营收约是布鲁克菲尔德的1.1倍($3.2B vs $3.0B),福泰制药净利率更高(37.3% vs 17.0%,领先20.3%),福泰制药同比增速更快(9.5% vs 4.7%)
布鲁克菲尔德是加拿大跨国企业,为全球规模最大的另类投资管理机构之一,管理资产规模超1万亿美元,资金多来自全球公共养老金的雇员递延收入,投资覆盖地产、可再生能源、基础设施、信贷、私募股权领域,2019年收购橡树资本后拓展了不良证券投资业务。
福泰制药是总部位于美国马萨诸塞州波士顿的生物制药企业,是全球首批明确采用理性药物设计策略、而非组合化学方法开发药物的生物技术公司之一。除波士顿总部外,公司还在加州圣迭戈、英国牛津郡米尔顿公园设有三处研发中心。
BNT vs VRTX — 直观对比
营收规模更大
VRTX
是对方的1.1倍
$3.0B
营收增速更快
VRTX
高出4.9%
4.7%
净利率更高
VRTX
高出20.3%
17.0%
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $3.0B | $3.2B |
| 净利润 | $516.0M | $1.2B |
| 毛利率 | — | 85.4% |
| 营业利润率 | 20.0% | 37.8% |
| 净利率 | 17.0% | 37.3% |
| 营收同比 | 4.7% | 9.5% |
| 净利润同比 | 91.8% | 30.5% |
| 每股收益(稀释后) | — | $4.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BNT
VRTX
| Q4 25 | — | $3.2B | ||
| Q3 25 | — | $3.1B | ||
| Q2 25 | $3.0B | $3.0B | ||
| Q1 25 | — | $2.8B | ||
| Q4 24 | — | $2.9B | ||
| Q3 24 | — | $2.8B | ||
| Q2 24 | $2.9B | $2.6B | ||
| Q1 24 | — | $2.7B |
净利润
BNT
VRTX
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | $516.0M | $1.0B | ||
| Q1 25 | — | $646.3M | ||
| Q4 24 | — | $913.0M | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | $269.0M | $-3.6B | ||
| Q1 24 | — | $1.1B |
毛利率
BNT
VRTX
| Q4 25 | — | 85.4% | ||
| Q3 25 | — | 86.5% | ||
| Q2 25 | — | 86.3% | ||
| Q1 25 | — | 86.9% | ||
| Q4 24 | — | 85.5% | ||
| Q3 24 | — | 85.8% | ||
| Q2 24 | — | 85.9% | ||
| Q1 24 | — | 87.3% |
营业利润率
BNT
VRTX
| Q4 25 | — | 37.8% | ||
| Q3 25 | — | 38.6% | ||
| Q2 25 | 20.0% | 38.8% | ||
| Q1 25 | — | 22.7% | ||
| Q4 24 | — | 35.2% | ||
| Q3 24 | — | 40.3% | ||
| Q2 24 | -1.0% | -132.9% | ||
| Q1 24 | — | 42.4% |
净利率
BNT
VRTX
| Q4 25 | — | 37.3% | ||
| Q3 25 | — | 35.2% | ||
| Q2 25 | 17.0% | 34.8% | ||
| Q1 25 | — | 23.3% | ||
| Q4 24 | — | 31.4% | ||
| Q3 24 | — | 37.7% | ||
| Q2 24 | 9.3% | -135.8% | ||
| Q1 24 | — | 40.9% |
每股收益(稀释后)
BNT
VRTX
| Q4 25 | — | $4.64 | ||
| Q3 25 | — | $4.20 | ||
| Q2 25 | — | $3.99 | ||
| Q1 25 | — | $2.49 | ||
| Q4 24 | — | $3.62 | ||
| Q3 24 | — | $4.01 | ||
| Q2 24 | — | $-13.92 | ||
| Q1 24 | — | $4.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $17.5B | $6.6B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $15.8B | $18.7B |
| 总资产 | $148.9B | $25.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
BNT
VRTX
| Q4 25 | — | $6.6B | ||
| Q3 25 | — | $6.3B | ||
| Q2 25 | $17.5B | $6.4B | ||
| Q1 25 | — | $6.2B | ||
| Q4 24 | — | $6.1B | ||
| Q3 24 | — | $6.5B | ||
| Q2 24 | $17.2B | $5.8B | ||
| Q1 24 | — | $10.2B |
股东权益
BNT
VRTX
| Q4 25 | — | $18.7B | ||
| Q3 25 | — | $17.3B | ||
| Q2 25 | $15.8B | $17.2B | ||
| Q1 25 | — | $16.5B | ||
| Q4 24 | — | $16.4B | ||
| Q3 24 | — | $15.6B | ||
| Q2 24 | $9.0B | $14.8B | ||
| Q1 24 | — | $18.5B |
总资产
BNT
VRTX
| Q4 25 | — | $25.6B | ||
| Q3 25 | — | $24.9B | ||
| Q2 25 | $148.9B | $24.0B | ||
| Q1 25 | — | $22.9B | ||
| Q4 24 | — | $22.5B | ||
| Q3 24 | — | $22.2B | ||
| Q2 24 | $130.5B | $20.1B | ||
| Q1 24 | — | $23.9B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $498.0M |
| 自由现金流经营现金流 - 资本支出 | — | $348.6M |
| 自由现金流率自由现金流/营收 | — | 10.9% |
| 资本支出强度资本支出/营收 | — | 4.7% |
| 现金转化率经营现金流/净利润 | — | 0.42× |
| 过去12个月自由现金流最近4个季度 | — | $3.2B |
8季度趋势,按日历期对齐
经营现金流
BNT
VRTX
| Q4 25 | — | $498.0M | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $818.9M | ||
| Q4 24 | — | $584.6M | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | — | $-3.8B | ||
| Q1 24 | — | $1.3B |
自由现金流
BNT
VRTX
| Q4 25 | — | $348.6M | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $927.4M | ||
| Q1 25 | — | $778.2M | ||
| Q4 24 | — | $492.0M | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $-3.8B | ||
| Q1 24 | — | $1.2B |
自由现金流率
BNT
VRTX
| Q4 25 | — | 10.9% | ||
| Q3 25 | — | 37.0% | ||
| Q2 25 | — | 31.3% | ||
| Q1 25 | — | 28.1% | ||
| Q4 24 | — | 16.9% | ||
| Q3 24 | — | 47.0% | ||
| Q2 24 | — | -144.5% | ||
| Q1 24 | — | 46.0% |
资本支出强度
BNT
VRTX
| Q4 25 | — | 4.7% | ||
| Q3 25 | — | 3.3% | ||
| Q2 25 | — | 4.9% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 2.4% | ||
| Q2 24 | — | 2.6% | ||
| Q1 24 | — | 2.5% |
现金转化率
BNT
VRTX
| Q4 25 | — | 0.42× | ||
| Q3 25 | — | 1.15× | ||
| Q2 25 | — | 1.04× | ||
| Q1 25 | — | 1.27× | ||
| Q4 24 | — | 0.64× | ||
| Q3 24 | — | 1.31× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.19× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BNT
暂无分部数据
VRTX
| TRIKAFTAKAFTRIO | $2.6B | 81% |
| ALYFTREK | $380.1M | 12% |
| Manufactured Product Other | $237.4M | 7% |